Ruthie Amir

Ruthie Amir

Chief Tech/Sci/R&D Officer chez SOFWAVE MEDICAL LTD.

58 ans
Health Technology
Finance
Consumer Services

Profil

Dr. Ruthie Amir joined Alon Medtech Ventures as the chief medical officer in 2018.
Prior to joining Alon Medtech Dr. Amir served as the director of clinical research and the head of the regulatory department of Syneron Candela from 2008 to 2017.
Dr. Ruthie Amir graduated from Ben Gurion University Medical School in 1989.
From 1996-2000, she completed her post-doctoral fellowship in the Department of Human Genetic, at Baylor College of Medicine, Houston, USA where she worked on the genetic basis of Rett Syndrome.
Between 2000-2003 she completed a post-doctoral fellowship in the Department of Cell Biology, Faculty of Medicine, Technion.

Postes actifs de Ruthie Amir

SociétésPosteDébut
SOFWAVE MEDICAL LTD. Chief Tech/Sci/R&D Officer 01/10/2018
EPITOMEE MEDICAL LTD Corporate Officer/Principal 01/05/2018
Corporate Officer/Principal 01/09/2017
Tous les postes actifs de Ruthie Amir

Anciens postes connus de Ruthie Amir

SociétésPosteFin
SYNERON MEDICAL LTD. Chief Tech/Sci/R&D Officer 01/01/2017
Voir l'expérience en détail de Ruthie Amir

Formation de Ruthie Amir

Medical School For International Health Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ruthie Amir

Relations

53

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
EPITOMEE MEDICAL LTD

Health Technology

SOFWAVE MEDICAL LTD.

Health Technology

Entreprise privées2

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Ruthie Amir